Goldstein Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1M Buy
3,947
+351
+10% +$81.8K 0.09% 82
2026
Q1
$879K Buy
3,596
+40
+1% +$9.32K 0.1% 74
2025
Q4
$736K Buy
3,556
+6
+0.2% +$1.19K 0.08% 81
2025
Q3
$658K Sell
3,550
-69
-2% -$11.8K 0.08% 86
2025
Q2
$553K Sell
3,619
-35
-1% -$5.38K 0.07% 88
2025
Q1
$606K Sell
3,654
-621
-15% -$97.2K 0.09% 79
2024
Q4
$618K Sell
4,275
-220
-5% -$34.1K 0.09% 79
2024
Q3
$728K Buy
4,495
+18
+0.4% +$2.87K 0.11% 68
2024
Q2
$654K Buy
4,477
+947
+27% +$141K 0.11% 66
2024
Q1
$558K Buy
3,530
+122
+4% +$19.4K 0.1% 75
2023
Q4
$534K Buy
3,408
+29
+0.9% +$4.45K 0.09% 98
2023
Q3
$526K Sell
3,379
-282
-8% -$46.5K 0.11% 70
2023
Q2
$606K Sell
3,661
-8
-0.2% -$1.29K 0.13% 65
2023
Q1
$569K Buy
3,669
+121
+3% +$19.5K 0.13% 68
2022
Q4
$627K Buy
+3,548
New +$613K 0.15% 63

Other funds holding JNJ

Goldstein Advisors's JNJ Position: Q2 2026 in Review

Goldstein Advisors increased its Johnson & Johnson (JNJ) stake by 9.8% in Q2 2026, buying an estimated $81.8K and bringing the position to 3,947 shares worth $1M. The position accounts for 0.09% of the portfolio, ranked #82.

Goldstein Advisors first reported a position in JNJ in Q4 2022 and has held it in 15 quarters since. 4,672 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Goldstein Advisors held 3,947 shares of Johnson & Johnson worth $1M as of Q2 2026.
  • Goldstein Advisors bought 351 Johnson & Johnson shares in Q2 2026, an estimated $81.8K.
  • Johnson & Johnson made up 0.09% of Goldstein Advisors's portfolio in Q2 2026, its #82 holding.
  • Goldstein Advisors first reported a position in Johnson & Johnson in Q4 2022 and has held it in 15 quarters since.
  • 4,672 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Goldstein Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.